Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.

Lukefahr AL, Frye JB, Wright LE, Marion SL, Hoyer PB, Funk JL.

Calcif Tissue Int. 2012 Mar;90(3):239-49. doi: 10.1007/s00223-011-9565-2. Epub 2012 Jan 17.

3.
4.

Pseudo-isolated FSH deficiency caused by an inhibin B-secreting granulosa cell tumour: case report.

Krishnan A, Murdock C, Allard J, Cisar M, Reid E, Nieman L, Segars J.

Hum Reprod. 2003 Mar;18(3):502-5. Review.

PMID:
12615814
5.

The role of FSH and TSH in bone loss and its clinical relevance.

Agrawal M, Zhu G, Sun L, Zaidi M, Iqbal J.

Curr Osteoporos Rep. 2010 Dec;8(4):205-11. doi: 10.1007/s11914-010-0028-x. Review.

PMID:
20809202
6.

A role for inhibin in the regulation of the secretion of follicle stimulating hormone in male domestic animals.

Tilbrook AJ, de Kretser DM, Clarke IJ.

Domest Anim Endocrinol. 1992 Oct;9(4):243-60. Review. No abstract available.

PMID:
1473345
7.

The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic Syndrome.

Brooks HL, Pollow DP, Hoyer PB.

Physiology (Bethesda). 2016 Jul;31(4):250-7. doi: 10.1152/physiol.00057.2014. Review.

8.

The immunobiology of follicle-stimulating hormone and inhibin: prospects for a contraceptive vaccine.

Moudgal NR.

Curr Opin Immunol. 1989-1990;2(5):736-42. Review. No abstract available.

PMID:
2518397
9.

Emerging concepts in the epidemiology, pathophysiology, and clinical care of postmenopausal osteoporosis.

Lizneva D, Yuen T, Sun L, Kim SM, Atabiekov I, Munshi LB, New M, Zaidi M.

Matrix Biol. 2018 May 5. pii: S0945-053X(18)30158-6. doi: 10.1016/j.matbio.2018.05.001. [Epub ahead of print] Review.

PMID:
29738833

Supplemental Content

Support Center